|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/47 | |
| A61K 31/557 | |||
| A61P 27/06 |
| (11) | Number of the document | 3461484 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18206195.2 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2019-04-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361787883 P | 2013-03-15 | US |
| (72) |
Kopczynski, Casey, US
Lin, Cheng-Wen, US
Sturdivant, Jill Marie, US
Delong, Mitchell, A, US
|
| (73) |
Aerie Pharmaceuticals, Inc.,
7020 Kit Creek Road, Suite 270 Research Triangle Park P.O. Box 12320, Durham, NC 27709,
US
|
| (54) | DIMESYLATE SALTS OF 4-(3-AMINO-1-(ISOQUINOLIN-6-YLAMINO)-1-OXOPROPAN-2-YL)BENZYL, THEIR COMBINATIONS WITH PROSTAGLANDINS AND THE USE THEREOF IN THE TREATMENT OF OCULAR DISORDERS |
| DIMESYLATE SALTS OF 4-(3-AMINO-1-(ISOQUINOLIN-6-YLAMINO)-1-OXOPROPAN-2-YL)BENZYL, THEIR COMBINATIONS WITH PROSTAGLANDINS AND THE USE THEREOF IN THE TREATMENT OF OCULAR DISORDERS |